Neutra Corp. (NTRR)
| Previous Close | 0.0003 |
| Open | 0.0003 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0003 - 0.0003 |
| 52 Week Range | 0.0002 - 0.0007 |
| Volume | |
| Avg. Volume | 4,914,981 |
| Market Cap | 875,370 |
| Beta (5Y Monthly) | 3.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireNeutra Reflects on 2023 and Looks Forward to 2024
HOUSTON, TX, Dec. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neutra Corporation (OTC PINK:NTRR), an emerging health and wellness research and development company, reflects on the 2023 year and plans for moving forward in 2024. In the previous press release, Neutra announced a medium-term management plan to meet the rapidly increasing demand for the company's modern approach to specialty health and wellness solutions. Currently, the acquisition has been put on hold due to some internal hous
- GlobeNewswire
Neutra Announces Strategic and Financial Value Creation Plan
HOUSTON, TX, Oct. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Neutra Corporation (OTC PINK: NTRR), an emerging health and wellness research and development company, announces today a two-year, medium-term management plan in order to meet the rapidly increasing demand for the company's modern approach to specialty health and wellness solutions. The strategic plan helps strengthen the shift towards the service business to grow its health and wellness portfolio and formalizes its pursuit of con
- GlobeNewswire
Neutra Nearing Expansion Into Growing Health, Wellness and Life Sciences Sector
HOUSTON, TX, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neutra Corporation (OTC PINK:NTRR) is thrilled to announce that it is in the final stages of acquiring an established clinical research site management organization, Mercury Clinical Research. With this exciting deal, Neutra will be able to expand into the booming health and wellness and life sciences sector, a rapidly growing market predicted to grow by over 6% annually through the 2020s. Mercury Clinical Research is a privately-
